Evaluation shows safety and effectiveness for the management of localized prostate cancer
Patients on dialysis die from cancer at twice the rate as those of the same age and sex in the general population, a study found.
Investigators report findings from the largest analysis characterizing objective imaging response among patients with mRCC treated in routine clinical practice.
Cancer-related monthly mortality rate higher in April 2020 when health care capacity was most challenged
FDA received licensing applications sooner and had shorter review times, compared to the European Medicines Agency
SHR3680 plus ADT improved radiographic progression-free survival and overall survival, when compared with bicalutamide plus ADT.
Among patients receiving radiation therapy (RT) for prostate cancer, intensity-modulated radiation therapy is significantly associated with a reduced risk for second primary solid malignancies compared with 3D conformal RT.
In hypothetical scenarios for a viral pandemic, willingness for surgery was higher with both patients and hospital staff vaccinated
Updated findings from the ENZAMET trial show that adding enzalutamide to testosterone suppression offers clinically meaningful improvements in overall survival.
Unmet social needs include family-level food insecurity, financial worry about housing costs and other monthly bills, and transportation challenges